Douglas Galasko

5.7k total citations
45 papers, 3.3k citations indexed

About

Douglas Galasko is a scholar working on Psychiatry and Mental health, Physiology and Molecular Biology. According to data from OpenAlex, Douglas Galasko has authored 45 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 22 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Douglas Galasko's work include Dementia and Cognitive Impairment Research (22 papers), Alzheimer's disease research and treatments (21 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). Douglas Galasko is often cited by papers focused on Dementia and Cognitive Impairment Research (22 papers), Alzheimer's disease research and treatments (21 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). Douglas Galasko collaborates with scholars based in United States, Canada and Denmark. Douglas Galasko's co-authors include Eliezer Masliah, L. J. Thal, Lawrence A. Hansen, David P. Salmon, Robert D. Terry, L A Hansen, L. Robert Hill, Robert Katzman, Mark W. Bondi and Nelson Butters and has published in prestigious journals such as Science, American Journal of Psychiatry and Neurology.

In The Last Decade

Douglas Galasko

43 papers receiving 3.2k citations

Peers

Douglas Galasko

PHYSI

PMH

NEURO

Richard Harvey United Kingdom

Mirosław Bryś United States

Pietro Tiraboschi Italy

Richard Mayeux United States

Stéphanie Bombois France

Ging‐Yuek Robin Hsiung Canada

Thomas Leyhe Germany

Douglas Galasko United States

Lutz Froelich Germany

Ana Frank Spain

Richard Harvey United Kingdom

Douglas Galasko

1.2k ×0.7

PHYSI

1.2k ×0.8

PMH

435 ×0.7

NEURO

611 ×1.3

510 ×1.1

NEURO

Citations per year, relative to Douglas Galasko Douglas Galasko (= 1×) peers Richard Harvey

Countries citing papers authored by Douglas Galasko

Since Specialization

Citations

This map shows the geographic impact of Douglas Galasko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Galasko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Galasko more than expected).

Fields of papers citing papers by Douglas Galasko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Galasko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Galasko. The network helps show where Douglas Galasko may publish in the future.

Co-authorship network of co-authors of Douglas Galasko

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Galasko. A scholar is included among the top collaborators of Douglas Galasko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Galasko. Douglas Galasko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Edwards, Lauren, Denis S. Smirnov, Kelsey R. Thomas, et al.. (2025). Interactive effects of arterial stiffness and Alzheimer's disease risk on cognitive decline in older adults without dementia. Alzheimer s & Dementia. 21(9). e70632–e70632. 2 indexed citations

Edwards, Lauren, Amanda Gonzalez, Kelsey R. Thomas, et al.. (2025). Interactive effects of blood–brain barrier breakdown and Alzheimer's disease biomarker status on cognitive decline in older adults without dementia. Alzheimer s & Dementia. 21(11). e70910–e70910.

Galasko, Douglas, Brendan P. Lucey, Donald L. Elbert, et al.. (2024). A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer’s Disease. Alzheimer s Research & Therapy. 16(1). 151–151. 6 indexed citations

Gollan, Tamar H., Denis S. Smirnov, David P. Salmon, & Douglas Galasko. (2020). Failure to stop autocorrect errors in reading aloud increases in aging especially with a positive biomarker for Alzheimer’s disease.. Psychology and Aging. 35(7). 1016–1025. 7 indexed citations

Xiao, Mei-Fang, Desheng Xu, Michael T. Craig, et al.. (2017). NPTX2 and cognitive dysfunction in Alzheimer’s Disease. eLife. 6. 236 indexed citations

Kahle‐Wrobleski, Kristin, J. Scott Andrews, Mark Belger, et al.. (2017). DEPENDENCE LEVELS AS INTERIM CLINICAL MILESTONES ALONG THE CONTINUUM OF ALZHEIMER’S DISEASE: 18-MONTH RESULTS FROM THE GERAS OBSERVATIONAL STUDY. The Journal of Prevention of Alzheimer s Disease. 4(2). 1–9. 16 indexed citations

Kahle‐Wrobleski, Kristin, J. Scott Andrews, Mark Belger, et al.. (2015). CLINICAL AND ECONOMIC CHARACTERISTICS OF MILESTONES ALONG THE CONTINUUM OF ALZHEIMER’S DISEASE: TRANSFORMING FUNCTIONAL SCORES INTO LEVELS OF DEPENDENCE. The Journal of Prevention of Alzheimer s Disease. 2(2). 1–6. 6 indexed citations

Galasko, Douglas. (2013). The Diagnostic Evaluation of a Patient With Dementia. CONTINUUM Lifelong Learning in Neurology. 19(2). 397–410. 9 indexed citations

Pillai, Jagan A., Linda K. McEvoy, Donald J. Hagler, et al.. (2012). Higher education is not associated with greater cortical thickness in brain areas related to literacy or intelligence in normal aging or mild cognitive impairment. Journal of Clinical and Experimental Neuropsychology. 34(9). 925–935. 16 indexed citations

10.

Sano, Mary, Karen L. Bell, Douglas Galasko, et al.. (2011). A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology. 77(6). 556–563. 244 indexed citations

11.

Peavy, Guerry M., Mark W. Jacobson, David P. Salmon, et al.. (2011). The Influence of Chronic Stress on Dementia-related Diagnostic Change in Older Adults. Alzheimer Disease & Associated Disorders. 26(3). 260–266. 76 indexed citations

12.

Lessig, Stephanie, Kiren Ubhi, Douglas Galasko, et al.. (2010). Reduced hypocretin (orexin) levels in dementia with Lewy bodies. Neuroreport. 21(11). 756–760. 33 indexed citations

13.

Thal, Leon J., Kejal Kantarci, Eric M. Reiman, et al.. (2006). The Role of Biomarkers in Clinical Trials for Alzheimer Disease. Alzheimer Disease & Associated Disorders. 20(1). 6–15. 179 indexed citations

14.

Frank, Richard, Douglas Galasko, Harald Hampel, et al.. (2003). Biological markers for therapeutic trials in Alzheimer’s disease. Neurobiology of Aging. 24(4). 521–536. 198 indexed citations

15.

Weiner, Myron, Rochelle E. Tractenberg, Mary Sano, et al.. (2002). No Long-Term Effect of Behavioral Treatment on Psychotropic Drug Use for Agitation in Alzheimer's Disease Patients. Journal of Geriatric Psychiatry and Neurology. 15(2). 95–98. 19 indexed citations

16.

Rockwell, Enid, et al.. (2000). Psychopathology at initial diagnosis in dementia with Lewy bodies versus Alzheimer disease: comparison of matched groups with autopsy-confirmed diagnoses. International Journal of Geriatric Psychiatry. 15(9). 819–823. 33 indexed citations

17.

Ellis, Ronald J., Peter Seubert, Ruth Motter, et al.. (1998). Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans. Neuroscience Letters. 254(1). 1–4. 32 indexed citations

18.

Samuel, William, Douglas Galasko, Eliezer Masliah, & Lawrence A. Hansen. (1996). Neocortical Lewy Body Counts Correlate with Dementia in the Lewy Body Variant of Alzheimerʼs Disease. Journal of Neuropathology & Experimental Neurology. 55(1). 44–52. 112 indexed citations

19.

Galasko, Douglas, L A Hansen, Robert Katzman, et al.. (1994). Clinical-Neuropathological Correlations in Alzheimer's Disease and Related Dementias. Archives of Neurology. 51(9). 888–895. 317 indexed citations

20.

Hansen, Lawrence A., Eliezer Masliah, Douglas Galasko, & Robert D. Terry. (1993). Plaque-Only Alzheimer Disease is Usually the Lewy Body Variant, and Vice Versa. Journal of Neuropathology & Experimental Neurology. 52(6). 648–654. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact